Sun Lab

Our lab’s research focuses on drug discovery to inhibit cancer stem cells and nanomedicine for cancer therapeutics. We also study drug delivery and bioequivalence for drugs, and are conducting several clinical studies for drug dissolution in GI tract sponsored by the Food and Drug Administration. Dr. Sun serves as the Director of Pharmacokinetics (PK) Core in the University of Michigan. The PK Core mainly works on: A) To support preclinical pharmacokinetics and metabolism for lead compound selection and dose regimen optimization, which enhances drug discovery and development and B) To support clinical pharmacokinetics and optimize dose regimen in clinical studies. {Originally certified gold: February 13, 2017}